A true privilege to close out #GU21 by moderating the RCC rapid abstract session with Stephen Boorjian, MD to highlight new and innovative RCC data. Chun Loo Gan Shankar Siva Brian Rini, MD, Dr. Jonathon Thouvenin, and Dr. Grant Stewart

So exciting to see such beautiful data about Enfortumab vedotin in mUCC — improved PFS and OS means longer and better lives for patients with this difficult disease! #GU21

90% efficacy is similar to many widely-accepted and used immunizations. Not a virologist or immunologist but so glad to have hope for a vaccine that would protect my wonderful #GUoncology and #palliativecare patients

Beautiful talk by Suzanne Cole, MD at #IKCS2020 about real world use of TKI + IO combinations for treating metastatic #kidneycancer , including financial toxicity

Beautiful work by Shuchi Gulati MD for #IKCS2020 about identifying molecular gene signatures to serve as predictive biomarkers for localized #kidneycancer

Truly a great day to tackle #kidneycancer with multimodal therapy alongside Ivan Pedrosa and Rahul Sheth at #IKCS2020 . Especially loved highlighting #PalliativeCare as part of best practices foe all of us!

This 👇🏻

Students, faculty & staff, along w/colleagues from The University of Kansas Health System and KU Cancer Center, kneeled in solidarity today in recognition of the tragic violence and systemic racism facing the Black community. Now is the time to stand together to address racism. #WhiteCoatsforBlackLives

Many of us routinely push the eligibility criteria for patients with potentially curable disease, but will this extend to those with metastatic disease?

Practice-changing data for metastatic bladder cancer from JAVELIN 100 demonstrating significantly improved OS with post-chemo Avelumab maintenance #ASCO20

Impressive data to support Cabo + Atezo for mCRPC — truly novel therapy presented at #ASCO20 for this disease

Dear Emergency Medicine colleagues,
When this mess is over I vow not to give you a hard time if you want to admit someone with a remote history of cancer to the oncology service. If they need to be admitted to someone that someone can be me. Thank you for being THE front line.

Though the symbol of Valentine’s Day is a heart, it should be a kidney this year! Proud to support these great trials with my fellow investigators! #GU20

So excited to see this great work highlighted — so many patients with prostate cancer ask what else they can do for their cancer control and QOL and I love to see these so-called “lifestyle” interventions brought into conventional oncology care and research.

Kudos to PCF for highlighting importance of diet and exercise during #ProstateCancer treatment at ⁦ #PCFRetreat19 - Brian Focht from Ohio State shows both components require consistency to reduce ADT side effects. Adherence remains a challenge but patients are interested!